Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €44.33 EUR
Change Today -0.70 / -1.55%
Volume 0.0
CI2 On Other Exchanges
New York
As of 2:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

cantel medical corp (CI2) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - €45.96
52 Week Low
05/16/14 - €22.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CANTEL MEDICAL CORP (CI2)

Related News

No related news articles were found.

cantel medical corp (CI2) Related Businessweek News

No Related Businessweek News Found

cantel medical corp (CI2) Details

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. Its Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents, and other supplies used to disinfect flexible endoscopes; and disposable infection control products for cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures, as well as technical maintenance services on its products. The company’s Water Purification and Filtration segment provides water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage, and commercial industrial markets; and disinfectants, and decontamination services used in various applications for infection prevention and control. Its Healthcare Disposables segment offers single-use infection prevention and control healthcare products, including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups, and disinfectants used principally in the dental market; and biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care, and dental markets. The company’s Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. Its Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training for the transportation of infectious and biological specimens and thermally sensitive pharmaceutical, medical, and other products. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

1,534 Employees
Last Reported Date: 09/29/14
Founded in 1963

cantel medical corp (CI2) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $612.5K
President, Chief Operating Officer and Member...
Total Annual Compensation: $434.6K
Chairman and Member - Office of the Chairman
Total Annual Compensation: $325.0K
Executive Vice President
Total Annual Compensation: $346.9K
Executive Vice President, General Counsel and...
Total Annual Compensation: $346.9K
Compensation as of Fiscal Year 2014.

cantel medical corp (CI2) Key Developments

Cantel Medical Corp. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 12:10 PM

Cantel Medical Corp. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 12:10 PM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Andrew A. Krakauer, Chief Executive Officer and Director.

Cantel Medical Corp. Appoints Peter G. Clifford as Executive Vice President and Chief Financial Officer, Effective March 23, 2015

Cantel Medical Corp. announced the appointment of Peter G. Clifford as Executive Vice President and Chief Financial Officer. Mr. Clifford will join Cantel Medical on March 23rd and replace Craig A. Sheldon, whose planned retirement was previously announced. Mr. Sheldon will remain at Cantel as Executive Vice President through mid-May to assist in the transition. For the past six years, Mr. Clifford served as Vice President of Operations Finance and Information Technology of IDEX Corporation.

Cantel Medical Appoints Laura Forese to its Board of Directors

Cantel Medical Corp. announced the appointment of Dr. Laura Forese as a member of its Board of Directors. Dr. Forese serves as President of NewYork-Presbyterian Healthcare System, the comprehensive network of NewYork-Presbyterian that includes multiple acute care, community hospitals, employed and affiliated physician practice relationships, ambulatory facilities and post-acute institutions. She has been responsible for the strategy and execution of the rapidly evolving network that provides significant services to patients throughout the New York Region. Dr. Forese is also Group SVP and COO for NewYork-Presbyterian/Weill Cornell where she has responsibility for all programs and operations at the academic medical center and related campuses.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CI2:GR €44.33 EUR -0.70

CI2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr214.70 SEK +2.50
Hill-Rom Holdings Inc $51.94 USD +0.03
Mesa Laboratories Inc $85.25 USD +1.99
STERIS Corp $70.76 USD +0.06
Transcat Inc $10.10 USD -0.0299
View Industry Companies

Industry Analysis


Industry Average

Valuation CI2 Industry Range
Price/Earnings 46.1x
Price/Sales 3.8x
Price/Book 5.2x
Price/Cash Flow 46.1x
TEV/Sales 3.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANTEL MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at